Department of Biotechnology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Microgen Health Inc., 14225 Sullyfield Cir Suite E, Chantilly, VA 20151, USA.
Cells. 2022 Aug 28;11(17):2672. doi: 10.3390/cells11172672.
Diabetes mellitus is a severe metabolic disorder, which consistently requires medical care and self-management to restrict complications, such as obesity, kidney damage and cardiovascular diseases. The subtype gestational diabetes mellitus (GDM) occurs during pregnancy, which severely affects both the mother and the growing foetus. Obesity, uncontrolled weight gain and advanced gestational age are the prominent risk factors for GDM, which lead to high rate of perinatal mortality and morbidity. In-depth understanding of the molecular mechanism involved in GDM will help researchers to design drugs for the optimal management of the condition without affecting the mother and foetus. This review article is focused on the molecular mechanism involved in the pathophysiology of GDM and the probable biomarkers, which can be helpful for the early diagnosis of the condition. The early diagnosis of the metabolic disorder, most preferably in first trimester of pregnancy, will lead to its effective long-term management, reducing foetal developmental complications and mortality along with safety measures for the mother.
糖尿病是一种严重的代谢紊乱疾病,需要持续的医疗护理和自我管理,以限制肥胖、肾脏损伤和心血管疾病等并发症的发生。妊娠糖尿病(GDM)是一种在怀孕期间发生的糖尿病亚型,会严重影响母亲和正在成长的胎儿。肥胖、体重控制不佳和妊娠晚期是 GDM 的显著危险因素,会导致围产期死亡率和发病率升高。深入了解 GDM 涉及的分子机制将有助于研究人员设计出药物,以在不影响母亲和胎儿的情况下对其进行最佳管理。本文综述了 GDM 病理生理学中涉及的分子机制和可能的生物标志物,这有助于早期诊断该疾病。最好在妊娠早期进行代谢紊乱的早期诊断,这将有助于对其进行有效的长期管理,减少胎儿发育并发症和死亡率,并为母亲提供安全措施。